Alerus Financial NA Takes $205,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Alerus Financial NA purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,405 shares of the financial services provider’s stock, valued at approximately $205,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BNP Paribas Financial Markets increased its stake in iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Cetera Investment Advisers raised its stake in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after purchasing an additional 79,541 shares in the last quarter. State of Michigan Retirement System lifted its position in iShares Biotechnology ETF by 150.0% during the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares during the period. Finally, Aristides Capital LLC acquired a new stake in iShares Biotechnology ETF during the second quarter worth about $9,180,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $141.55 on Monday. The firm has a 50 day moving average of $142.71 and a 200-day moving average of $142.06. iShares Biotechnology ETF has a 12 month low of $119.95 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.